ArticleChronic obstructive pulmonary diseases (Miami, Fla.)2019

Nebulized Versus Dry Powder Long-Acting Muscarinic Antagonist Bronchodilators in Patients With COPD and Suboptimal Peak Inspiratory Flow Rate.

Donald A Mahler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.